Pharmidex will attend: "Advanced Therapies Integrates 2025"
December 1, 2025
📢 Pharmidex is pleased to announce that our Business Development Manager, Janette Dalay Robertson, will attend Advanced Therapies Integrates 2025
🗓 2nd December 2025
📍 Victoria House, London
Janette Dalay Robertson looks forward to meeting industry and academic attendees to strengthen relationships and explore new collaborations that support innovation in drug discovery and development.
🤝 Let’s connect and drive the future of advanced therapies together.
#AdvancedTherapies #Pharmidex #DrugDiscovery #Collaboration
The Pharmidex team will be in London for London Life Sciences Week from the 16th. Janette Dalay Robertson and Ash Alavijeh will be attending a range of events across the week. We are looking forward to a busy week discussing all things life-science related. Get in touch if you’d like to meet with us during the week as we visit existing clients and stakeholders!
Our Head of Integrated Therapeutics and CNS, Dr. Stephen Mitchell , our Business Development Manager, Janette Dalay Robertson and our Senior Research Scientist in CNS, Jewel Ahmed will be there to engage with attendees, share insights and explore new collaborations driving innovation in Parkinson’s disease drug discovery and development. If you’re attending, don’t hesitate to reach out, they’ll be delighted to connect and discuss how Pharmidex’s integrated expertise can help move your research from concept to clinic.
We are delighted to share that Prof. Mo Alavijeh will be attending the upcoming 🔬 OBN (UK) Ltd BioTuesday: A Spotlight on the Latest R&D for the Diagnosis & Treatment of Prostate Cancer 📅 11 November 2025 📍 Ipsen, Paddington, London This event brings together leading experts and innovators shaping the future of prostate cancer research and therapy. If you’re attending, don’t miss the opportunity to meet with Prof. Mo Alavijeh (FRSC, FRSM), and explore how collaboration can accelerate progress in drug discovery and development.
